Further preliminary assessment of three human glioma cell lines as models of human astrocytic toxicity in vitro

Environmental Toxicology and Pharmacology

Volumn 26, Issue 3, 2008, Pages 290-296

  Holden, Lindsay J ^a   Coleman, Michael D ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Ethanol; GFAP; Gliomas; IL 6; LPS; MTT; Toxicity; Trimethyltin chloride

Indexed keywords

ACRYLAMIDE; ALCOHOL; BACTERIUM LIPOPOLYSACCHARIDE; CHLOROQUINE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 6; OXIDOREDUCTASE; TRIMETHYLTIN;

ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BACTERIA (MICROORGANISMS);

EID: 52949140806     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2008.05.009     Document Type: Article

References (63)

1. Abbott N.J. Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 200 (2002) 629-638
2. Aubert I., Ridet J.L., and Gage F.H. Regeneration in the adult mammalian CNS; guided by development. Curr. Opin. Neurobiol. 5 (1995) 625-635
3. Brahmachari S., Fung Y.K., and Pahan K. Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J. Neurosci. 26 (2006) 4930-4939
4. Brittis P.A., Meiri K., Dent E., and Silver J. The earliest patterns of neuronal differentiation and migration in the mammalian central nervous system. Exp. Neurol. 134 (1995) 1-12
5. Bruccoleri A., Brown H., and Harry G.J. Cellular localization and temporal elevation of tumor necrosis factor-alpha, interleukin-1 alpha and transforming growth factor-beta 1 mRNA in hippocampal injury response induced by trimethyltin. J. Neurochem. 71 (1998) 1577-1587
6. Butler D., Brown Q.B., Chin D.J., Batey L., Karim S., Mutneja M.S., Karanian D.A., and Bahr B.A. Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation. Rejuv. Res. 8 (2005) 227-237
7. Coecke S., Eskes C., Gartlon J., Kinsner A., Price A., van Vliet E., Prieto P., Boveri M., Bremer S., Adler S., Pellizer C., Wendel A., and Hartung T. The value of alternative testing for neurotoxicity in the context of regulatory needs. Env. Tox. Pharm. 21 (2006) 153-167
8. Coleman M.D., Zilz T.R., Griffiths H.R., and Woehrling E.K. comparison of the apoptotic and cytotoxic effects of hexanedione derivatives on human non-neuronal lines and the neuroblastoma line SH-SY5Y. Basic Clin. Pharm. Toxicol. 102 (2008) 25-29
9. Cookson M.R., and Pentreath V.W. Alterations in the glial fabrillary acidic protein content of primary astrocyte cultures for evaluation of glial cell toxicity. Toxicol. In Vitro 8 (1994) 351-359
10. Cookson M.R., McClean R., Williams S.P., Davenport-Jones J., Egan C., O'hre S., Atterwill C.K., and Pentreath V.W. Use of astrocytes for in vitro neurotoxicity testing. Toxicol. In Vitro 8 (1994) 817-819
11. Combes R.D. Why "suitable" in vitro methods, as defined in the final EU REACH legislation, are an inappropriate basis for risk assessment. Alt. Lab. Anim. 35 (2007) 289-293
12. Dearfield K.L., Douglas G.R., Ehling G.R., Moore U.H., Sega G.A., and Bruskick D.J. Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk. Mutat. Res. 330 (1995) 71-99
13. Eddleston M., and Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience 54 (1993) 15-36
14. Eng L.F., Ghirnikar R.S., and Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 25 (2000) 1439-1451
15. Espevik T., Otterlei M., Skjak-Braek G., Ryan L., Wright S.D., and Sundan A. The involvement of CD14 in stimulation of cytokine production of uronic acid polymers. Eur. J. Immunol. 23 (1993) 255-261
16. Farooqui A.A., Ong W.Y., and Horrocks L.A. Inhibitors of brain phospholipase A(2) activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol. Rev. 58 (2006) 591-620
17. Gartlon J., Kinsner A., Bal-Price A., Coecke S., and Clothier R.H. Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity. Toxicol. In Vitro 20 (2006) 1569-1581
18. Gerlier D., and Thomasset N. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods 94 (1986) 57-63
19. Greiffenstein P., Mathis K.W., Stouwe C.V., and Molina P. Alcohol binge before trauma/hemorrhage impairs integrity of host defense mechanisms during recovery. Alcoholism Clin. Exp. Res. 31 (2007) 704-715
20. Grimaldi M., Navarra P., Pozzoli G., Preziosi P., and Schettini G. Bacterial lipopolysaccharide increases interleukin-6 and prostaglandin release in rat cortical type 1 astrocytes by different mechanisms: role of anti-inflammatory agents. Biochem. Biophys. Res. Commun. 250 (1998) 798-804
21. Grindon C. The new EU REACH regulation has finally been adopted: is this the end of the campaign trail... or just the beginning?. Alt. Lab. Anim. 35 (2007) 239-242
22. Harry G.J., Sills R., Schlosser M.J., and Maier W.E. Neurodegeneration and glia response in rat hippocampus following nitro-l-arginine methyl ester (l-NAME). Neurotoxicol. Res. 3 (2001) 307-319
23. Harry G.J., Tyler K., d'Hellencourt C.L., Tilson H.A., and Maier W.E. Morphological alterations and elevations in tumor necrosis factor-alpha, interleukin (IL)-1alpha, and IL-6 in mixed glia cultures following exposure to trimethyltin: modulation by proinflammatory cytokine recombinant proteins and neutralizing antibodies. Toxicol. Appl. Pharmacol. 180 (2002) 205-218
24. Holden L.J., and Coleman M.D. Assessment of the astrogliotic responses of three human astrocytoma cell lines to ethanol, trimethyltin chloride, and acrylamide. Toxicology 241 (2007) 75-83
25. Iravani M.M., Leung C.C., Sadeghian M., Haddon C.O., Rose S., and Jenner P. The acute and long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. Eur. J. Neurosci. 22 (2005) 317-330
26. Ishibashi T., Dakin K.A., Stevens B., Lee P.R., Koslov S.V., Stewart C.L., and Fields R.D. Astrocytes promote myelination in response to electrical impulses. Neuron 49 (2006) 823-832
27. Jean-Harry G., Bruccoleri A., and Lefebvre-d'Hellencourt C. Differential modulation of hippocampal chemical-induced injury response by ebselen, pentoxifylline and TNFalpha-, IL-1alpha- and IL-6 neutralizing antibodies. J. Neurosci. Res. 73 (2003) 526-536
28. Jeong J.Y., and Jue D.M. Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages. J. Immunol. 158 (1997) 4901-4907
29. Johansson A., Engler H., Blomquist G., Scott B., Wall A., Aquilonius S.M., Langstrom B., and Askmark H. Evidence for astrocytosis in ALS demonstrated by [C-11](l)-deprenyl-D2 PET. J. Neurol. Sci. 255 (2007) 17-22
30. Karres I., Kremer J.P., Dietl I., Steckholzer U., Jochum M., and Ertel W. Chloroquine inhibits proinflammatory cytokine release into whole human blood. Am. J. Physiol. 274 (1998) R1058-R1064
31. Lam H.R., Ladefoged O., Ostergaard G., and O'Callaghan J.P. Inhalation exposure to white spirit causes region-dependent alterations in the levels of glial fibrillary acidic protein. Neurotoxicol. Teratol. 22 (2000) 725-731
32. Letournel-Boulland M.L., Fages C., Rolland B., and Tardy M. Lipopolysaccharides (LPS) up-regulate the IL-1-mRNA and down-regulate the glial fibrillary acidic protein (GFAP) and glutamine synthetase (GS)-mRNAs in astroglial primary cultures. Eur. Cytokine Net. 5 (1994) 51-56
33. Lopachin R.M., and Aschner M. Glial neuronal interactions-relevance to neurotoxic mechanisms. Toxicol. Appl. Pharmacol. 118 (1993) 141-158
34. Loppnow H., Libby P., Freudenberg M., Krauss J.H., Weckesser J., and Meyer H. Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by non-toxic Rhodobacter capsulatus LPS. Infect. Immunol. 58 (1990) 3743-3750
35. Maier W.E., Brown H.W., Tilson H.A., Luster M.I., and Harry G.J. Trimethyltin increases interleukin (IL)-1 alpha. IL-6 and tumor necrosis factor alpha mRNA levels in rat hippocampus. J. Neuroimmunol. 59 (1995) 65-75
36. Malhotra S.K., Predy R., Johnson E.S., Singh R., and Leeuw K. Novel astrocytic protein in multiple sclerosis plaques. J. Neurosci. Res. 22 (1989) 36-69
37. Malhotra S.K., Shnitka T.K., and Elbrink J. Reactive astrocytes-a review. Cytobios 61 (1990) 133-160
38. McDermott K.W., Barry D.S., and McMahon S.S. Role of radial glia in cytogenesis, patterning and boundary formation in the developing spinal cord. J. Anat. 207 (2005) 241-250
39. McVicker B.L., Tuma D.J., Kharbanda K.K., Kubik J.L., and Casey C.A. Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells. Alcoholism Clin. Exp. Res. 31 (2007) 122-129
40. Mead C., and Pentreath V.W. Evaluation of toxicity indicators in rat primary astrocytes, C6 glioma and human 1321N1 astrocytoma cells: can gliotoxicity be distinguished from cytotoxicity?. Arch. Toxicol. 72 (1998) 372-380
41. Murphy K.G., Hatton J.D., and Hoi Sang U. Role of glial fibrillary acidic protein expression in the biology of human glioblastoma U-373MG cells. J. Neurosurg. 89 (1998) 997-1006
42. Netea M.G., van Deuren M., Kullberg B.J., Cavaillon J.M., and Van de Meer J.W.M. Does the shape of lipid A determine the interaction of LPS with toll-like receptors?. Trends Immunol. 23 (2002) 135-139
43. O'Callaghan J.P. Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 13 (1991) 275-281
44. Oh J.W., Schwiebert L.M., and Benveniste E.N. Cytokine regulation of CC and CXC chemokine expression in human astrocytes. J. Neurovirol. 5 (1999) 82-94
45. Palma C., Urbani F., and Manzini S. Interleukin-6 production by U373 MG, a human astrocytoma cell line: different pathways involved in substance P and lipopolysaccharide activation. J. Neuroimmunol. 59 (1995) 155-163
46. Park J., Kwon D., Choi C., Oh J.W., and Benveniste E.N. Chloroquine induces activation of nuclear factor-κB and subsequent expression of pro-inflammatory cytokines by human astroglial cells. J. Neurochem. 84 (2003) 1266-1274
47. Pentreath V.W., and Slamon N.D. Astrocyte phenotype and prevention against oxidative damage in neurotoxicity. Hum. Exp. Toxicol. 19 (2000) 641-649
48. Pentreath V.W., and Mead C. Responses to cultured astrocyte, C6 glioma and 1321N1 astrocytoma cells to amyloid beta-peptide fragments. Non-Lin. Biol. Toxicol. Med. 2 (2004) 45-63
49. Saravia F., Beauquis J., Pietranera L., and De Nicola A.F. Neuroprotective effects of estradiol in hippocampal neurons and glia of middle age mice. Psychoneuroendocrinology 32 (2007) 480-492
50. Sharif S.F., Hariri R.J., Chang V.A., Barie P.S., Wang R.S., and Ghajar J.B. Human astrocyte production of tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 following exposure to lipopolysaccharide endotoxin. Neurol. Res. 15 (1993) 109-112
51. Sugaya K., Chou S., Xu S.J., and McKinney M. Indicators of glial activation abd brain oxidative stress after intraventricular infusion of endotoxin. Brain Res. 58 (1998) 1-9
52. Tada H., Shiho O., Kuroshima K., Koyama M., and Tsukamoto K. An improved colorimetric assay for interleukin-2. J. Immunol. Methods 93 (1986) 157-165
53. Toimela T.A., and Tahti H. Effects of mercury, methylmercury and aluminium on glial fibrillary acidic protein expression in rat cerebellar astrocyte cultures. Toxicol. In Vitro 9 (1995) 317-325
54. Tsacopoulos M. Metabolic signalling between neurons and glial cells: a short review. J. Physiol. Paris 96 (2002) 283-288
55. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., Viviani B., Marinovich M., Cerami A., Coleman T.R., Brines M., and Ghezzi P. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 198 (2003) 971-975
56. van den Borne B.E., Dijkmans B.A., de Rooij H.H., le Cessie S., and Verweij C.L. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-α, interleukin-6 and interferon-γ production by peripheral blood mononuclear cells. J. Rheumatol. 24 (1997) 55-60
57. von Boyen G.B.T., Steinkamp M., Reinshagen M., Schafer K.H., Adler G., and Kirsch J. Proinflammatory cytokines increase glial fabrillary acidic protein expression in enteric glia. Gut 53 (2004) 222-228
58. Vitkovic L., Wood G.P., Major E.O., and Fauci A.S. Human astrocytes stimulate HIV-1 expression in a chronically infected promonocyte clone via interleukin-6. AIDS Res. Hum. Retrovir. 7 (1991) 723-727
59. Wang J.H., and Sun G.Y. Ethanol inhibits cytokine-induced iNOS and sPLA(2) in immortalized astrocytes: evidence for posttranscriptional site of ethanol action. J. Biomed. Sci. 8 (2001) 126-133
60. Woehrling E.K., Hill E.J., and Coleman M.D. Development of a neurotoxicity test-system using human post-mitotic astrocytic and neuronal cell lines in co-culture. Toxicol. In Vitro 21 (2007) 1241-1246
61. Woehrling E.K., Zilz T.R., and Coleman M.D. The effects of hexanediones on neural and astrocytic cell lines. Env. Tox. Pharmacol. 22 (2006) 249-254
62. Zhang Y.H., Lin J.X., and Vilcek J. Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol. Cell Biol. 10 (1990) 3818-3823
63. Zilz T.R., Griffiths H.R., and Coleman M.D. Apoptotic and necrotic effects of hexanedione derivatives on the human neuroblastoma line SK-N-SH. Toxicology 231 (2007) 210-214